Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHINE: Intensive vs Standard Insulin in Stroke
NCT01369069Phase 3Completed
- Sponsor
- University of Virginia
- Start
- Apr 2012
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of regular human insulin in hyperglycemia (2 arms), sponsored by University of Virginia. Primary endpoints: Modified Rankin Scale Favorable Outcome at 90 days and Severe Hypoglycemia at 72 hours. Started Apr 2012; status: completed.
02
Drugs
regular human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT01369069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369069.